BRIEF-FDA approves Amgen's Amjevita (Adalimumab-Atto)
September 23, 2016 at 18:19 PM EDT
* Amgen Inc says Amjevita is Amgen's first biosimilar to receive regulatory approval
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.